Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil X Anand

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 8, 2010
Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibitionSunil X Anand, Juan F Viles-Gonzalez, Sohail K Mahboobi, et al.
Thrombosis and Haemostasis|September 6, 2003
Membrane-associated CD40L and sCD40L in atherothrombotic diseaseSunil X Anand, Juan F Viles-Gonzalez, Juan J Badimon, et al.
Journal of Cardiovascular Pharmacology|April 9, 2004
Tissue factor coagulation pathway: a new therapeutic target in atherothrombosisJuan F Viles-Gonzalez, Sunil X Anand, M Urooj Zafar, et al.
European Heart Journal|March 1, 2005
Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging studyJuan F Viles-Gonzalez, Valentin Fuster, Roberto Corti, et al.
Journal of the American College of Cardiology|February 11, 2003
The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administrationJonathan D Marmur, Sunil X Anand, Ramanjit S Bagga, et al.
The Mount Sinai Journal of Medicine, New York|May 28, 2004
Update in atherothrombotic diseaseJuan F Viles-Gonzalez, Sunil X Anand, Carolina Valdiviezo, et al.
The American Journal of Cardiology|July 31, 2007
Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudinSunil X Anand, Michael C Kim, Mazullah Kamran, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 8, 2010
Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibitionSunil X Anand, Juan F Viles-Gonzalez, Sohail K Mahboobi, et al.
Thrombosis and Haemostasis|September 6, 2003
Membrane-associated CD40L and sCD40L in atherothrombotic diseaseSunil X Anand, Juan F Viles-Gonzalez, Juan J Badimon, et al.
Journal of Cardiovascular Pharmacology|April 9, 2004
Tissue factor coagulation pathway: a new therapeutic target in atherothrombosisJuan F Viles-Gonzalez, Sunil X Anand, M Urooj Zafar, et al.
European Heart Journal|March 1, 2005
Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging studyJuan F Viles-Gonzalez, Valentin Fuster, Roberto Corti, et al.
Journal of the American College of Cardiology|February 11, 2003
The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administrationJonathan D Marmur, Sunil X Anand, Ramanjit S Bagga, et al.
The Mount Sinai Journal of Medicine, New York|May 28, 2004
Update in atherothrombotic diseaseJuan F Viles-Gonzalez, Sunil X Anand, Carolina Valdiviezo, et al.
The American Journal of Cardiology|July 31, 2007
Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudinSunil X Anand, Michael C Kim, Mazullah Kamran, et al.
Pageof 1